| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Nymox's New Trial For Benign Prostatic Hyperplasia Drug Records Positive ...RTT News - Nov 23, 2009 The St. Laurent, Canada-based company said that BPH causes difficulties with urination associated with aging, such as urination at night, ... Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for ... CNNMoney.com (press release) Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, UnilifeSeeking Alpha (blog) - - Nov 25, 2009 BPH Essential Treatment with Thermobalancing Therapy Restores Potency by Fine ...SBWire (press release) - Nov 24, 2009 New treatment for BPH helps to keep a prostate in healthy condition thereby restores potency and increases libido. This BPH essential treatment tackles the ... New EDM 165 - Treatment for Prostate Diseases DeHavilland (press release) (subscription) Resistive index: A newly identified predictor of outcome of transurethral ...UroToday - Nov 26, 2009 A total of 572 men aged 51-85 years scheduled to undergo TURP for benign prostatic hyperplasia were prospectively enrolled, and 560 were ultimately ... Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction/Positive ...PR Newswire (press release) - Nov 18, 2009 Approximately 65% in this ED trial also had lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) as assessed by the ... Almirall receives positive recommendation for silodosin from EMEAZenopa - Nov 27, 2009 This applies to doses of 4 mg, 8 mg and hard capsules of the drug - which is intended for the treatment of the symptoms of benign prostatic hyperplasia ... BPH Drug May Raise TestosteroneRenal and Urology News - - Nov 19, 2009 Dutasteride treatment for benign prostatic hyperplasia (BPH) is associated with a significant increase in serum testosterone and a significant decrease in ... Admin error forces GSK to withdraw Avodart prostate cancer sNDAPharma Times - - Nov 24, 2009 GlaxoSmithKline has withdrawn a supplemental New Drug Application in the USA for its benign prostatic hyperplasia treatment Avodart though the move is not ... Committee For Medicinal Products For Human Use Summary Of Positive Opinion For ...PharmaLive.com (press release) - Nov 20, 2009 The benefits with Silodyx are its ability to improve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) including ... Committee For Medicinal Products For Human Use Post-Authorisation Summary Of ... PharmaLive.com (press release) Committee For Medicinal Products For Human Use Summary Of Positive Opinion For ... PharmaLive.com (press release) HairDX (RxR) Genetic Test Helps Doctors Assess The Risk For Benign Prostatic ...NewsBlaze - Nov 17, 2009 Benign Prostatic Hyperplasia (BPH) is the age-related overgrowth of specific prostate tissues, which often progresses to enlargement of the prostate. ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests... Bernard von NotHaus (Liberty Dollar) Aubrey de Grey, PhD Dr. Amanuel Sima, MD Dr. Bard Levey, DDS Neal Adams Robin Scovill (director) Richard Diaz (author) Dr. Kaayla T. Daniel, CCN Chana de Wolf, (cryonics researcher) Dr. Mary Ruwart (author & scientist) Richard Diaz (author) Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |